- Corporate & Securities
- Corporate Governance
- Mergers & Acquisitions
- Technology, Communications & Media
- Venture Capital & Emerging Companies
- Life Sciences
|Contact Info||Telephone: 617.239.8491|
Internet: Each Attorney's Internet Address takes the following form: first initial, last name @mintz.com (e.g., email@example.com)
|University ||Dartmouth College, B.A.|
|Law School||Harvard University, J.D.|
|Admitted||1973, Massachusetts; District of Columbia|
• Member, International Bar Association
• Member, American Bar Association
• Member, Massachusetts Bar Association
• Member, Boston Bar Association
Rich concentrates on domestic and cross-border merger and acquisition (M&A) representation and corporate fiduciary counseling.
In his M&A and other transactional practice, Rich represents boards of public and private companies, board committees, and individual directors in a wide variety of business combination transactions and other circumstances. He also has broad corporate finance experience, representing entrepreneurs, companies and investors.
In his corporate fiduciary duty advisory practice, Rich is often called upon to advise companies, boards, and board committees regarding strategic alternatives, unsolicited takeover bids, activist shareholder interaction, antitakeover preparedness, and related-party matters as to which heightened duties apply. Much of this activity in recent times has been focused on the firm's life sciences industry clients.
He was instrumental in 2000 in establishing the firm's New York office, now the firm's second-largest office.
Awards & Recognitions
•Martindale-Hubbell AV Preeminent
• Panelist, Shareholders' Agreements: Shareholders' Disputes in Family Owned Companies, International Bar Association Annual Meeting, International Bar Association, Boston, MA (10.07.2013)
|Reported Cases||Representative Matters: M&A & Other Transactional Practice Spyglass, Inc. (NASDAQ: SPYG) underwriters in the first Internet company IPO, as well as issuers in multiple other public offerings, and companies and venture capital investors in numerous venture capital investments; America Online, Inc. (NYSE: AOL) in its acquisitions of CompuServe, Inc. (NASDAQ: CMPU) and Mirabilis Ltd. (ICQ) and other matters; Xyplex, Inc. in its sale to the Raytheon Company (NYSE: RTN); Steinway Musical Properties, Inc. in its leveraged purchase from CBS and subsequent divestitures; Steinway Musical Properties, Inc. in its sale to the Selmer Company, renamed Steinway Musical Instruments, Inc. (NYSE: LVB); Ekco Group, Inc. (NYSE: EKO) in its management buyout (MBO) and multiple later M&A transactions; Advantage Health Corporation (NASDAQ: ADHC) in its sale to HealthSouth Corporation (NYSE: HLS); Atex Media Solutions, Inc. in multiple acquisitions, including that of Unisys Media with assets and operations in 15 countries; Atex Media Solutions, Inc. in its reorganization into a UK holding company, Atex Group Limited, and a rights offering and equity placement; Cedara Software Corporation (TSX: CDE / NASDAQ: CDSW) in its acquisition of eMed Technologies, Inc. Lavastorm Technologies, Inc. in its sale to Martin Dawes Systems Limited; Fastclick, Inc. (NASDAQ: FSTC) in its sale to ValueClick, Inc. (NASDAQ: VCLK); Funk Software, Inc. in its sale to Juniper Networks, Inc. (NYSE: JNR); Visual Sciences, LLC in its sale to WebSideStory, Inc. (NASDAQ: WSSI); The DeWolfe Companies, Inc. (AMEX: DWL) in its sale to Cendant Corporation (NYSE: CD); Collective Brands, Inc. (NYSE: PSS) in its purchase of Stride Rite Corporation (NYSE: SRR) (Massachusetts counsel); Hellman & Friedman in its purchase of Kronos Incorporated (NASDAQ: KRON) (Massachusetts counsel); Myrexis, Inc. (NASDAQ: MYRX) in its pursuit of strategic alternatives and extraordinary dividend to stockholders; Chyron Corporation (NASDAQ: CHYR) in its purchase of Hego AB Special Committee& Independent Director Representation Ticketmaster (NASDAQ: TKTM) special committee in the sale of the public shareholders' equity to IAC/InterActiveCorp (NASDAQ: IACI); Terra Networks S.A., aka Terra Lycos (NASDAQ: TRLY), independent directors in a strategic agreement with its control shareholder, Telefonica S.A. (NYSE: TEF); The Princeton Review, Inc. (NASDAQ: REVU) special committee in a Bain Capital-led strategic financing; TRC Companies, Inc. (NYSE: TRR) special committee in a related-party PIPE financing; Alcon, Inc. (NYSE: ACL) independent director in the sale of the public shareholders' equity to Novartis AG; deCODE genetics, Inc. (NASDAQ: DCGN) special committee in its sale to Saga Investments LLC; Orchid Cellmark, Inc. (NASDAQ: ORCH) special committee in its sale to Laboratory Corp. of America Holdings (NYSE: LH); Steinway Musical Instruments, Inc. (NYSE: LVB) special committee in various related-party matters; Macquarie Infrastructure Company, LLC (NYSE: MIC) independent directors in various related-party matters|
View Ratings & Reviews
|Profile Visibility |
|#1,708 in weekly profile views out of 19,840 lawyers in Boston, Massachusetts|
|#114,626 in weekly profile views out of 1,606,920 total lawyers Overall|